NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

May 12, 2016

Primary Completion Date

April 3, 2017

Study Completion Date

April 3, 2017

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG

Netupitant/Palonosetron

All Listed Sponsors

lead

Consorzio Oncotech

OTHER

NCT03862144 - NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter